DENVER, CO — An independent analysis of three registries run by St Jude Medical saw vanishingly low rates of mechanical failure of the company's implantable defibrillator leads insulated with the ...
Pacing Clin Electrophysiol. 2013;36(9):1055-1058. Implantable cardioverter defibrillator (ICD) therapy is a proven, life-saving technology. However, everything comes at a cost. Current transvenous ...
Oct 6 (Reuters) - Generic drugmaker Actavis Plc said it would acquire Durata Therapeutics Inc in a deal valued at about $675 million to bolster its infectious disease portfolio. Durata's shares were ...
Actavis plans to acquire Durata Therapeutics for $675 million-plus, the companies said today, in a deal that broadens the buyer’s portfolio with the already-marketed infectious disease drug Dalvance™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results